Hyperfine, Inc. - stock earnings
HYPR Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -10.7 million USD | 2.7 million USD |
| 2023Q3 | -10.8 million USD | 2.3 million USD |
| 2023Q2 | -10.6 million USD | 3.4 million USD |
| 2023Q1 | -11.3 million USD | 2.6 million USD |
| 2022Q4 | -12.7 million USD | 1.4 million USD |
| 2022Q3 | -12.9 million USD | 2.3 million USD |
| 2022Q2 | -23.1 million USD | 1.5 million USD |
| 2022Q1 | -23.8 million USD | 1.5 million USD |
| 2021Q4 | -26.1 million USD | 436000 USD |
| 2021Q3 | -16.4 million USD | 371000 USD |
| 2021Q2 | -14.6 million USD | 358000 USD |
| 2021Q1 | -7.8 million USD | 331000 USD |
| 2020Q4 | -6.9 million USD | 207000 USD |
HYPR Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -44.2 million USD | 11.0 million USD |
| 2022 | -72.5 million USD | 6.8 million USD |
| 2021 | -64.8 million USD | 1.5 million USD |
| 2020 | -23.4 million USD | 294000 USD |
| 2019 | -18.8 million USD | ? USD |
HYPR
Price: $0.83
52 week price:
Earnings Per Share: -0.62 USD
P/E Ratio: -1.65
Exchange: NGM
Sector: Healthcare
Industry: Medical Devices
Volume: 182898
Market Capitalization: 60.1 million